Viewing Study NCT06349850



Ignite Creation Date: 2024-05-06 @ 8:21 PM
Last Modification Date: 2024-10-26 @ 3:26 PM
Study NCT ID: NCT06349850
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-16
First Post: 2024-03-31

Brief Title: Predictive Value of Serum Uric Acid to HDL Cholesterol Ratio for Diabetic Kidney Injury in Type 2 Diabetes
Sponsor: Sohag University
Organization: Sohag University

Study Overview

Official Title: Predictive Value of Serum Uric Acid to High Density Lipoprotein Cholesterol Ratio for Diabetic Kidney Injury in Type 2 Diabetes
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: An prospective observetional study to asses the predictive value of serum uric acid to high density lipoprotein cholesterol ratio for diabetic kidney injury in type 2 diabetes
Detailed Description: Diabetic Kidney Injury DKI is a serious microvascular complication of diabetes mellitus occuring in about 20 to 50 of diabetic patients and is the single commonest cause of ESRDDKI is asociated with arterial HTN and increased cardiovascular morbidity and mortality outcomes for both type 1 DM and type 2 DM who develop DKI are significantly worse than who do not Serum uric acid was reported to be asociated with inflamatory and metabolic diseases such as metabolic syndrome type 2 DMthyroiditis and NAFLD while HDL-cholesterol decreased the odds of developing DKI by 20It is generally accepted that hyperuricemia and low HDL-c were considered to be a risk factor of other indicators for development of DKI

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None